Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes

Diabetes

Volumn 56, Issue 6, 2007, Pages 1592-1599

  Mogensen, Martin ^a   Sahlin, Kent ^a,b,c   Fernström, Maria ^b,c   Glintborg, Dorte ^d   Vind, Birgitte F ^d   Beck Nielsen, Henning ^d   Højlund, Kurt ^d  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b SWEDISH SCHOOL OF SPORT AND HEALTH SCIENCES   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; 4 HYDROXYNONENAL; ADENOSINE DIPHOSPHATE; BIOLOGICAL MARKER; CITRATE SYNTHASE; MALIC ACID; PALMITOYLCARNITINE; PYRUVIC ACID; UNCOUPLING PROTEIN 3;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; ISOLATION PROCEDURE; MALE; MITOCHONDRIAL RESPIRATION; MUSCLE BIOPSY; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RESPIRATORY CHAIN; SKELETAL MUSCLE; STATISTICAL ANALYSIS;

3-HYDROXYACYL COA DEHYDROGENASES; BIOPSY; BLOOD GLUCOSE; CITRATE (SI)-SYNTHASE; DIABETES MELLITUS, TYPE 2; ELECTRON TRANSPORT; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; OBESITY; OXYGEN CONSUMPTION; REFERENCE VALUES;

EID: 34249720640     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0981     Document Type: Article

References (50)

1. Beck-Nielsen H, Vaag A, Poulsen P, Gaster M: Metabolic and genetic influence on glucose metabolism in type 2 diabetic subjects: experiences from relatives and twin studies. Best Pract Res Clin Endocrinol Metab 17:445-467, 2003
2. Petersen KF, Shulman GI: Etiology of insulin resistance. Am J Med 119 (Suppl. 1):S10-S16, 2006
3. 2-terminal sites during physiological hyperinsulinemia in type 2 diabetes. Diabetes 52:1393-1402, 2003
4. Kelley DE, Goodpaster BH, Storlien L: Muscle triglyceride and insulin resistance. Annu Rev Nutr 22:325-346, 2002
5. Levin K, Daa Schroeder H, Alford FP, Beck-Nielsen H: Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with type II diabetes. Diabetologia 44:824-833, 2001
6. Brehm A, Krssak M, Schmid AI, Nowotny P, Waldhausl W, Roden M: Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes 55:136-140, 2006
7. Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS: Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci U S A 100:7996-8001, 2003
8. Kelley DE, Mandarino LJ: Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49:677-683, 2000
9. Kelley DE, Simoneau JA: Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 94:2349-2356, 1994
10. Kelley DE, Goodpaster B, Wing RR, Simoneau JA: Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277:E1130-E1141, 1999
11. Simoneau JA, Kelley DE: Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83:166-171, 1997
12. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA: Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 279:E1039-E1044, 2000
13. Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE: Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J 13:2051-2060, 1999
14. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ: Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100:8466-8471, 2003
15. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC: PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267-273, 2003
16. Sreekumar R, Halvatsiotis P, Schimke JC, Nair KS: Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51:1913-1920, 2002
17. Hojlund K, Wrzesinski K, Larsen PM, Fey SJ, Roepstorff P, Handberg A, Dela F, Vinten J, McCormack JG, Reynet C, Beck-Nielsen H: Proteome analysis reveals phosphorylation of ATP synthase beta-subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J Biol Chem 278:10436-10442, 2003
18. Kelley DE, He J, Menshikova EV, Ritov VB: Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51:2944-2950, 2002
19. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE: Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54:8-14, 2005
20. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI: Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664-671, 2004
21. Iossa S, Mollica MP, Lionetti L, Crescenzo R, Tasso R, Liverini G: A possible link between skeletal muscle mitochondrial efficiency and age-induced insulin resistance. Diabetes 53:2861-2866, 2004
22. Madsen K, Ertbjerg P, Pedersen PK: Calcium content and respiratory control index of isolated skeletal muscle mitochondria: effects of different isolation media. Anal Biochem 237:37-41, 1996
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
24. Tonkonogi M, Sahlin K: Rate of oxidative phosphorylation in isolated mitochondria from human skeletal muscle: effect of training status. Acta Physiol Scand 161:345-353, 1997
25. Mogensen M, Bagger M, Pedersen PK, Fernstrom M, Sahlin K: Cycling efficiency in humans is related to low UCP3 content and to type I fibres but not to mitochondrial efficiency. J Physiol 571:669-681, 2006
26. Wibom R, Hagenfeldt L, von DU: Measurement of ATP production and respiratory chain enzyme activities in mitochondria isolated from small muscle biopsy samples. Anal Biochem 311:139-151, 2002
27. Mogensen M, Sahlin K: Mitochondrial efficiency in rat skeletal muscle: influence of respiration rate, substrate and muscle type. Acta Physiol Scand 185:229-236, 2005
28. Passonneau JV, Lowry OH: Enzymatic Analysis: A Practical Guide. Totowa, NJ, Humana Press, 1993
29. Alp PR, Newsholme EA, Zammit VA: Activities of citrate synthase and NAD+-linked and NADP+-linked isocitrate dehydrogenase in muscle from vertebrates and invertebrates. Biochem J 154:689-700, 1976
30. Andersen JL, Aagaard P: Myosin heavy chain IIX overshoot in human skeletal muscle. Muscle Nerve 23:1095-1104, 2000
31. Hansen EA, Andersen JL, Nielsen JS, Sjogaard G: Muscle fibre type, efficiency, and mechanical optima affect freely chosen pedal rate during cycling. Acta Physiol Scand 176:185-194, 2002
32. Tonkonogi M, Fernstrom M, Walsh B, Ji LL, Rooyackers O, Hammarqvist F, Wernerman J, Sahlin K: Reduced oxidative power but unchanged antioxidative capacity in skeletal muscle from aged humans. Pflugers Arch 446:261-269, 2003
33. Shabalina IG, Petrovic N, Kramarova TV, Hoeks J, Cannon B, Nedergaard J: UCP1 and defense against oxidative stress: 4-hydroxy-2-nonenal effects on brown fat mitochondria are uncoupling protein 1-independent. J Biol Chem 281:13882-13893, 2006
34. Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599-622, 2002
35. Fridlyand LE, Philipson LH: Reactive species and early manifestation of insulin resistance in type 2 diabetes. Diabetes Obes Metab 8:136-145, 2006
36. Choksi KB, Boylston WH, Rabek JP, Widger WR, Papaconstantinou J: Oxidatively damaged proteins of heart mitochondrial electron transport complexes. Biochim Biophys Acta 1688:95-101, 2004
37. Blomstrand E, Radegran G, Saltin B: Maximum rate of oxygen uptake by human skeletal muscle in relation to maximal activities of enzymes in the Krebs cycle. J Physiol 501:455-460, 1997
38. Fernstrom M, Tonkonogi M, Sahlin K: Effects of acute and chronic endurance exercise on mitochondrial uncoupling in human skeletal muscle. J Physiol 554:755-763, 2004
39. Tonkonogi M, Krook A, Walsh B, Sahlin K: Endurance training increases stimulation of uncoupling of skeletal muscle mitochondria in humans by non-esterified fatty acids: an uncoupling-protein-mediated effect? Biochem J 351:805-810, 2000
40. Oberbach A, Bossenz Y, Lehmann S, Niebauer J, Adams V, Paschke R, Schon MR, Bluher M, Punkt K: Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes. Diabetes Care 29:895-900, 2006
41. Hickey MS, Carey JO, Azevedo JL, Houmard JA, Pories WJ, Israel RG, Dohm GL: Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. Am J Physiol 268:E453-E457, 1995
42. He J, Watkins S, Kelley DE: Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 50:817-823, 2001
43. Zierath JR, He L, Guma A, Odegoard WE, Klip A, Wallberg-Henriksson H: Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 39:1180-1189, 1996
44. Lillioja S, Young AA, Culter CL, Ivy JL, Abbott WG, Zawadzki JK, Yki-Jarvinen H, Christin L, Secomb TW, Bogardus C: Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 80:415-424, 1987
45. Marin P, Andersson B, Krotkiewski M, Bjorntorp P: Muscle fiber composition and capillary density in women and men with NIDDM. Diabetes Care 17:382-386, 1994
46. Russell AP, Wadley G, Hesselink MK, Schaart G, Lo S, Leger B, Garnham A, Kornips E, Cameron-Smith D, Giacobino JP, Muzzin P, Snow R, Schrauwen P: UCP3 protein expression is lower in type I, IIa and IIx muscle fiber types of endurance-trained compared to untrained subjects. Pflugers Arch 445:563-569, 2003
47. Anderson EJ, Neufer PD: Type II skeletal myofibers possess unique properties that potentiate mitochondrial H(2)O(2) generation. Am J Physiol Cell Physiol 290:C844-C851, 2006
48. Schrauwen P, Hesselink MK: Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 53:1412-1417, 2004
49. Brand MD, Esteves TC: Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab 2:85-93, 2005
50. Schrauwen P, Mensink M, Schaart G, Moonen-Kornips E, Sels JP, Blaak EE, Russell AP, Hesselink MK: Reduced skeletal muscle UCP3 protein content in pre-diabetic subjects and type 2 diabetic patients: restoration by rosiglitazone treatment. J Clin Endocrinol Metab 2005